GlassScriptPhysician profile
Logan Gillen
NPI 1508539438
$653.19
in general payments reported to CMS, 2019-2025
13 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.68 · 2022: $20.37 · 2023: $136 · 2024: $204 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $273.95 | 2023-2025 | |
| Pfizer INC. | $104.62 | 2024-2025 | |
| Abiomed | $57.58 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $35.04 | 2024 | Xarelto |
| Argon Medical Devices, INC. | $32.27 | 2025 | Clot Management |
| Merck Sharp & Dohme LLC | $28.10 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $24.68 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.37 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.64 | 2024 | Eliquis |
| Cardiva Medical, INC. | $16.62 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $16.37 | 2025 | Synergy Ablation System |
| Terumo Medical Corporation | $15.13 | 2023 | Metacross Otw, Glidewire |
| Surmodics, INC. | $10.82 | 2025 | Pounce Xl Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Gillen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.